Perceived symptom improvement*
| Symptom | Mean [n = 28 (%, SD)] | Median [n = 28 (%, IQR)] |
|---|---|---|
| Sleep | 41.3 (46.3) | 37.5 (78.8) |
| Pain | 32.1 (41.5) | 30.0 (56.3) |
| Anxiety | 22.1 (37.0) | 12.5 (50) |
| Depression | 22.7 (40.0) | 2.5 (57.5) |
*: symptom improvement measured on a percentage scale with 100% being complete improvement
We thank all patients and staff who were involved in the project. We acknowledge Fonda Betts, Tanya Adams, and Greenleaf Medical Clinic.
ENRS: Data curation, Formal analysis, Investigation, Methodology, Validation, Writing—original draft. CAM: Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Validation, Writing—review & editing. LAL: Formal analysis, Investigation, Methodology, Validation, Writing—review & editing. JD: Data curation, Project administration, Supervision, Writing—review & editing. AC and KR: Data curation, Investigation, Validation, Writing—review & editing. CP: Writing—review & editing. WJP: Conceptualization, Funding acquisition, Resources, Writing—review & editing. AMB: Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing—original draft.
CAM has received consulting fees or honoraria from Andira, Active Patch Technologies, Dosist, Strainprint, Emerald Health Therapeutics, Sapphire Clinics, Aleafia, Spectrum, Tilray, Numinus, Aurora and MD Briefcase. She is on the Board of Directors for the Green Organic Dutchmen. The other authors report no potential conflicts.
Study ethics for this chart review were approved by the Clinical Research Ethics Board of the University of British Columbia (H17-03359) and complies with Declaration of Helsinki.
Informed consent to participate in the study was obtained from all participants.
Not applicable.
Data cannot be shared due to the stipulations of the ethics approval to ensure privacy of the patients involved.
AMB was funded by an
© The Author(s) 2023.